BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34117242)

  • 1. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
    Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
    Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
    Chen J; Li Y; Wu J; Liu Y; Kang S
    Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
    Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
    J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of 87 ovarian germ cell tumors.
    Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
    Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent In Situ Hybridization Analysis for 12p Alterations in Sarcomatoid Yolk Sac Tumors.
    Idrees MT; Ulbright TM; Epstein JI
    Am J Surg Pathol; 2019 Nov; 43(11):1566-1573. PubMed ID: 31478941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
    Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
    Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets.
    Kubota Y; Seki M; Kawai T; Isobe T; Yoshida M; Sekiguchi M; Kimura S; Watanabe K; Sato-Otsubo A; Yoshida K; Suzuki H; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Hiwatari M; Oka A; Hayashi Y; Miyano S; Ogawa S; Hata K; Tanaka Y; Takita J
    Commun Biol; 2020 Sep; 3(1):544. PubMed ID: 32999426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
    Cheasley D; Nigam A; Zethoven M; Hunter S; Etemadmoghadam D; Semple T; Allan P; Carey MS; Fernandez ML; Dawson A; Köbel M; Huntsman DG; Le Page C; Mes-Masson AM; Provencher D; Hacker N; Gao Y; Bowtell D; deFazio A; Gorringe KL; Campbell IG
    J Pathol; 2021 Jan; 253(1):41-54. PubMed ID: 32901952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor.
    Fujii H; Yamada Y; Yamamura K; Ishida Y; Tsujimura M; Matsumoto K; Tanaka S; Date H; Nishikawa T; Yoshida Y; Kashima J; Yatabe Y; Ogawa S; Marx A; Ulbright TM; Haga H
    Virchows Arch; 2023 May; 482(5):923-927. PubMed ID: 36943470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line.
    Shibata K; Umezu T; Sakurai M; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
    Gynecol Obstet Invest; 2011; 71(2):104-11. PubMed ID: 21150160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: A Second Primary Endodermal Sinus Tumor 9 Years after Initial Diagnosis.
    Moukarzel LA; Levinson K; Grumbine FC
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):259-261. PubMed ID: 27818263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.
    Skowron MA; Kotthoff M; Bremmer F; Ruhnke K; Parmaksiz F; Richter A; Küffer S; Reuter-Jessen K; Pauls S; Stefanski A; Ströbel P; Stühler K; Nettersheim D
    Mol Med; 2023 Mar; 29(1):40. PubMed ID: 36991316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and Characterization of a Novel Primitive Yolk Sac Tumour Cell Line, TC587.
    Iwasaki T; Kohashi K; Ohno M; Taguchi T; Oda Y
    Anticancer Res; 2020 Feb; 40(2):759-766. PubMed ID: 32014918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.
    Jenderny J; Köster E; Meyer A; Borchers O; Grote W; Harms D; Jänig U
    Hum Genet; 1995 Dec; 96(6):644-50. PubMed ID: 8522320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
    Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
    Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
    Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
    Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.